Alain Rinaldi

Dr. Rinaldi has founded in 2014 MedExpansion, a consulting company, to share his 30-year experience with biotechs developing treatments for rare and orphan diseases. He is a graduate of the Faculty of Medicine of Saint-Etienne (France) and he holds a Master in Business management from the Institut d’Administration des Entreprises (I.A.E.) of Lyon (France).

From 1984 to 1991 Alain has practiced as a paediatrician in Lyon, gaining a valuable experience of clinical medicine. In 1991, he joined the pharma industry where he has been serving on different senior positions until 2013 and acquired a wide experience in Medical Affairs, Marketing and Business development of drugs.
Amongst assignments, he had the opportunity to run several successful launchings of specialty drugs and to operate the strategic repositioning of a business unit of medical devices.

From 2006 to 2013 with Alexion, a US biotech company developing the orphan drug eculizumab (Soliris®), he has run the Medical Affairs department for France, Switzerland and CEE countries. He has built in those countries the medical foundations, implemented the clinical programs and organized the access to the treatment for patients suffering from life-threatening orphan diseases in onco-haematology, nephrology and transplantation.

Now in his new role with MedExpansion, Alain helps orphan drug companies to optimize their clinical developments and offer to patients an easier access to these treatments in Europe.

© 2018 Central & East European Health Policy Network
 
WILD CARDS
DOWNLOAD
 
 
STRATEGIC SCENARIOS 2020
LINK
 
 
CEE HPN brochure
DOWNLOAD
 
 
LOGO CEE HPN
DOWNLOAD
 
 
DESIGN MANUAL CEE HPN
DOWNLOAD